Predictive value of ATRIA risk score for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, cilt.65, sa.11, ss.1384-1390, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 65 Sayı: 11
- Basım Tarihi: 2019
- Doi Numarası: 10.1590/1806-9282.65.11.1384
- Dergi Adı: REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1384-1390
- Anahtar Kelimeler: ATRIA risk score, St-segment Elevation Myocardial Infarction, Contrast induced nephropathy, CHA(2)DS(2)-VASC SCORE, RENAL-FAILURE
- Süleyman Demirel Üniversitesi Adresli: Evet
Özet
BACKGROUND: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) risk score used to detect the thromboembolic and hemorrhagic risk in atrial fibrillation patients has been shown recently to predict poor clinical outcomes in patients with acute myocardial infarction (ACS), regardless of having atrial fibrillation (AF). We aimed to analyze the relationship between different risk scores and contrast-induced nephropathy (CIN) development in patients with ACS who underwent urgent percutaneous coronary intervention (PCI) and compare the predictive ability of the ATRIA risk score with the MEHRAN risk score.